Pharming Group N.V. - ADR

-0.03 (-0.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)773.30M
Current PE24.43
Forward PE 12.12
2yr Forward PE 10.36
See more stats
Estimates Current Quarter
Revenue$68.15 Million
Adjusted EPS$0.17
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Darwinweg 24, Leiden, Zuid-Holland 2332 CR
Phone: +31.71.524.74.00
Number of Employees:


Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.